Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
2 studies found for:    12163423 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Active, not recruiting Non-invasive Fractional Flow Reserve CT (FFRCT)Scan for the Study of Coronary Vaso-motion
Condition: Coronary Artery Disease
Intervention:
2 Completed
Has Results
Darusentan Effect on PET Uptake Heterogeneity
Conditions: Coronary Artery Disease;   Endothelial Dysfunction
Intervention: Drug: darusentan 100 mg

Study has passed its completion date and status has not been verified in more than two years.